Simulations Plus, Inc. (NASDAQ:SLP) has been assigned an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating.
Brokerages have set a 1 year consensus target price of $20.50 for the company and are forecasting that the company will post $0.12 EPS for the current quarter, according to Zacks. Zacks has also assigned Simulations Plus an industry rank of 99 out of 257 based on the ratings given to its competitors.
Several research analysts have recently commented on the stock. BidaskClub lowered shares of Simulations Plus from a “strong-buy” rating to a “buy” rating in a research note on Friday, November 2nd. Zacks Investment Research lowered shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Wednesday, September 19th.
A number of large investors have recently bought and sold shares of the stock. BlackRock Inc. grew its stake in Simulations Plus by 1.0% in the 3rd quarter. BlackRock Inc. now owns 854,735 shares of the technology company’s stock valued at $17,265,000 after buying an additional 8,281 shares during the last quarter. Renaissance Technologies LLC grew its stake in Simulations Plus by 2.6% in the 3rd quarter. Renaissance Technologies LLC now owns 607,400 shares of the technology company’s stock valued at $12,269,000 after buying an additional 15,300 shares during the last quarter. Vanguard Group Inc. grew its stake in Simulations Plus by 5.7% in the 3rd quarter. Vanguard Group Inc. now owns 559,928 shares of the technology company’s stock valued at $11,311,000 after buying an additional 30,153 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Simulations Plus by 7.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 545,994 shares of the technology company’s stock valued at $11,029,000 after buying an additional 39,930 shares during the last quarter. Finally, William Blair Investment Management LLC grew its stake in Simulations Plus by 17.6% in the 3rd quarter. William Blair Investment Management LLC now owns 418,609 shares of the technology company’s stock valued at $8,456,000 after buying an additional 62,733 shares during the last quarter. Institutional investors and hedge funds own 38.26% of the company’s stock.
Shares of SLP opened at $19.39 on Thursday. Simulations Plus has a 12 month low of $14.25 and a 12 month high of $23.95. The firm has a market cap of $326.80 million, a PE ratio of 38.78 and a beta of -0.73.
Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings results on Wednesday, November 14th. The technology company reported $0.07 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.01. Simulations Plus had a net margin of 30.11% and a return on equity of 24.97%. The company had revenue of $6.70 million for the quarter, compared to analyst estimates of $5.98 million. Research analysts forecast that Simulations Plus will post 0.52 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, November 8th. Investors of record on Thursday, November 1st were paid a $0.06 dividend. The ex-dividend date of this dividend was Wednesday, October 31st. This represents a $0.24 dividend on an annualized basis and a yield of 1.24%. Simulations Plus’s payout ratio is presently 48.00%.
Simulations Plus Company Profile
Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Read More: Trading Penny Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.